Jeff Paley
Direktor/Vorstandsmitglied bei IMMUNE PHARMACEUTICALS, INC.
Vermögen: 247 545 $ am 30.04.2024
Aktive Positionen von Jeff Paley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IMMUNE PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 23.02.2016 | - |
Independent Dir/Board Member | 23.02.2016 | - | |
Crimson Biomedical Consulting | Vorstandsvorsitzender | - | - |
Gründer | - | - | |
Remote Radiology, Inc. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Jeff Paley
Ehemalige bekannte Positionen von Jeff Paley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
JOURNEY MEDICAL CORPORATION | Direktor/Vorstandsmitglied | - | 07.12.2023 |
Independent Dir/Board Member | - | 07.12.2023 | |
AVENUE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.12.2015 | 05.04.2019 |
Independent Dir/Board Member | 01.12.2015 | 05.04.2019 | |
TRAVERE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 15.11.2013 | 10.09.2014 |
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - | - |
Weill Cornell Internal Medicine Associates
Weill Cornell Internal Medicine Associates Hospital/Nursing ManagementHealth Services Weill Cornell Internal Medicine Associates is a healthcare provider that offers paperless billing to its patients. The private company is located in New York, NY. The company also provides an Executive Health Program to help patients maximize their time and health. | Corporate Officer/Principal | - | - |
Access Medical Associates LLC | Gründer | 01.01.2003 | - |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Jeff Paley
Yeshiva University | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 15 |
Operativ
Director/Board Member | 9 |
Independent Dir/Board Member | 4 |
Founder | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
TRAVERE THERAPEUTICS, INC. | Health Technology |
AVENUE THERAPEUTICS, INC. | Health Technology |
CLARITAS PHARMACEUTICALS, INC. | Health Technology |
JOURNEY MEDICAL CORPORATION | Health Technology |
Private Unternehmen | 8 |
---|---|
Crimson Biomedical Consulting | |
KellBenx, Inc.
KellBenx, Inc. Medical SpecialtiesHealth Technology KellBenx, Inc. develops non-invasive prenatal diagnostics for analyzing genetic disorders and to determine a woman's risk of preterm delivery. The company was founded in 2010 and is headquartered in Great River, NY. | Health Technology |
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Kalytera Therapeutics, Inc. /Old/
Kalytera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Kalytera Therapeutics, Inc. develops non-psychoactive cannabinoid and endocannabinoid-like medicines that address the large unmet market needs. Its preclinical studies support the continued investigation of Kalytera drug candidates in a range of conditions, including bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan and David Stefansky in 2014 and is headquartered in Manhattan Beach, CA. | Health Technology |
Access Medical Associates LLC | |
Weill Cornell Internal Medicine Associates
Weill Cornell Internal Medicine Associates Hospital/Nursing ManagementHealth Services Weill Cornell Internal Medicine Associates is a healthcare provider that offers paperless billing to its patients. The private company is located in New York, NY. The company also provides an Executive Health Program to help patients maximize their time and health. | Health Services |
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Health Technology |
Remote Radiology, Inc. |
- Börse
- Insiders
- Jeff Paley
- Erfahrung